Common synthetic lethality partnersare BRCA1/2, which play a vital role in annealing RAD51 to ssDNA;however mutations in these proteins are quite common,161 and when this occurs, the cancer cell can compensateby utilizing RAD52 to perform the task instead. The gene discussed is RAD52; the disease is cancer.